LGND Latest Press Releases

-- April 28, 2026 --

XOMA Royalty Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of XOMA Royalty Corporation - XOMA Business Wire 12:45 PM

-- April 27, 2026 --

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation PRNewswire 3:06 PM

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand's Position as a Leading Biopharma Royalty Aggregator Globe Newswire 7:00 AM

-- April 22, 2026 --

Ligand to Report First Quarter 2026 Financial Results on May 7, 2026 Globe Newswire 7:00 AM

-- April 14, 2026 --

Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI (sparsentan) in FSGS Globe Newswire 7:00 AM

-- March 26, 2026 --

Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team Globe Newswire 7:00 AM

-- March 4, 2026 --

Ligand to Participate in March Investor Conferences Globe Newswire 7:00 AM

-- February 26, 2026 --

Ligand Reports Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 7:00 AM

-- February 12, 2026 --

Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 Globe Newswire 7:00 AM

-- February 4, 2026 --

Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference Globe Newswire 7:00 AM

-- December 9, 2025 --

Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software